Bayer Maintains its Support for Glyphosate Weedkiller Amidst Legal Challenges

author-image
Zara Nwosu
New Update
NULL

Bayer Maintains its Support for Glyphosate Weedkiller Amidst Legal Challenges

Bayer's CEO recently reaffirmed the company's commitment to its glyphosate weedkiller, despite ongoing legal challenges and controversy surrounding the product. This statement came as a surprise to many, following the company's recent courtroom loss in U.S. litigation, where it was alleged that their weedkiller has carcinogenic effects.

Backing Glyphosate Despite Controversy

As per reports, Bayer's CEO has been unwavering in their support for glyphosate, even amidst the significant controversy surrounding the weedkiller. The U.S. Securities and Exchange Commission recently announced that 16 firms, including Bayer, will pay over $81 million to settle charges for recordkeeping failures. However, Bayer continues to back its product, asserting its safety and efficacy.

Legal Challenges and Courtroom Losses

Despite Bayer's support, the company has faced significant legal setbacks with regards to its glyphosate weedkiller. In a recent ruling by the 11th US Circuit Court of Appeals, the German company's argument that federal law on pesticide labels should override state court claims was rejected. Plaintiffs have argued that Roundup, Bayer's glyphosate weedkiller, should come with a warning for cancer risk.

Continued Support Amidst Allegations

Despite the courtroom loss and ongoing litigation, Bayer's CEO continues to endorse glyphosate weedkiller. The CEO has stated that the product is approved and deemed safe by regulators in every major jurisdiction. This comes even after Bayer was ordered to pay a hefty $2.25 billion to a Pennsylvania man who developed cancer, allegedly due to exposure to glyphosate. The damages are expected to be reduced on appeal.

Roundup Lawsuits Update

Recent updates on Bayer's glyphosate weedkiller lawsuits reveal that Monsanto, which is owned by Bayer, has reached nearly 100,000 settlement agreements, paying approximately $11 billion. There are still over 40,000 active Roundup lawsuits and more than 4,000 claims in the MDL Roundup class action lawsuit pending in California. Some of the most recent verdicts have resulted in significant payouts, with the recent McKivision verdict amounting to a massive $2.25 billion, including $250 million in compensatory damages and $2 billion in punitive damages.

Bayer Not Shielded from Lawsuits

In a recent turn of events, a US appeals court ruled that Bayer is not shielded from lawsuits over its Roundup weedkiller. The court rejected Bayer's argument that federal environmental law protects it from liability, allowing the lawsuit to proceed. This ruling marks another significant blow to Bayer and its glyphosate weedkiller.

In conclusion, despite the ongoing legal challenges and significant financial implications, Bayer continues to stand behind its glyphosate weedkiller, Roundup. The company maintains that the product is safe and effective, as approved by regulators in major jurisdictions worldwide. However, with legal battles far from over, it remains to be seen how this situation will unfold for Bayer and its controversial weedkiller.